Abstract Oxidized low-density lipoprotein (oxLDL) has been characterized as an atherogenic molecule responsible for the induction of a variety of gene products. One such gene, tissue factor (TF), the cellular initiator of the coagulation cascade, is not expressed in normal vascular tissue but is expressed by monocytes and foam cells in atherosclerotic lesions. Therefore, we examined the effect of oxLDL on TF expression in cultured human adherent monocytes. Endotoxinfree oxLDL alone did not induce TF expression in adherent monocytes. However, oxLDL significantly enhanced TF expression induced by the inflammatory mediator, bacterial lipopolysaccharide (LPS), in a time-and dose-dependent manner. In contrast, oxLDL did not alter LPS-mediated
O xidized low-density lipoprotein (oxLDL) plays
an important role in the development of atheroma. 1 OxLDL has been detected in atherosclerotic lesions, 23 and human and rabbit sera contain antibodies against oxLDL. 34 Treatment of rabbits with potent antioxidants such as probucol, which may act by inhibiting LDL oxidation, substantially reduces the development of atherosclerotic lesions. 5 The three major cell types of the arterial wall, endothelial cells, macrophages, and smooth muscle cells, oxidize native LDL in vitro. 1 During oxidative modification LDL acquires biological properties, not present in the native molecule, that promote atherogenesis. For example, oxLDL is a chemoattractant for monocytes, increases monocyte adhesion to the endothelium, 6 enhances macrophage lipid accumulation, 1 and induces production of macrophage and other colony-stimulating factors. 7 In contrast, oxLDL inhibits the synthesis of platelet-derived growth factor 8 and bacterial lipopolysaccharide (LPS)-or maleylated albumin-induced mRNA expression of interleukin (IL)-la, IL-1/3, IL-6, and tumor necrosis factor (TNF)-a. 910 The transmembrane glycoprotein tissue factor (TF) serves as a receptor and essential cofactor for plasma coagulation factors VII/VIIa. 1112 The TF-VIIa complex activates coagulation factors IX and X by limited pro-teolysis, which ultimately leads to thrombin formation and fibrin deposition. 1112 Normally, TF is not expressed within the vasculature. 12 However, TF expression can be induced in monocytes and endothelial cells by a variety of agonists, including LPS and cytokines. 1214 More recently, acetylated LDL, malondialdehyde-modified LDL, and oxLDL have been reported to induce TF activity in monocytes/macrophages and endothelial cells. 1518 Pathological activation of the coagulation cascade by aberrant expression of TF on the surface of monocytes or endothelial cells is implicated in the pathogenesis of septic shock and various thromboembolic disorders. 13141920 In atherosclerotic plaques, TF antigen has been localized to monocyte-derived foam cells and vascular smooth muscle cells, 21 
"
23 suggesting a role for this receptor in atherogenesis.
In the present study, human plasma-derived adherent monocytes were chosen as a model to elucidate the possible physiological effect of oxLDL on TF expression. During the course of these studies, we observed significant levels of endotoxin contamination in preparations of oxLDL that induced TF expression in monocytes. Results of subsequent experiments with essentially "endotoxin-free" lipoproteins indicated that oxLDL alone had no significant effect on TF activity in adherent monocytes but significantly enhanced the inductive effect of low or intermediate doses of LPS in a specific and dose-dependent manner.
Methods Materials
glucose, Dulbecco's modified Eagle medium (DMEM) was prepared in the media kitchen at The Scripps Research Institute. The Limulus amebocyte lysate (LAL) assay kit for endotoxin and Ham's F-10 medium were purchased from Whittaker MA Bioproducts. LPS {Escherichia coli 0111 :B4) was obtained from Calbiochem.
Methods

Lipoprotein Isolation and Oxidation
LDL (rf=1.019 to 1.063 g/mL) was isolated from normal human plasma by sequential ultracentrifugation as described 24 and stored in DMEM/0.3 mmol/L EDTA for no longer than 4 weeks. LDL was oxidized at a concentration of 200 /ig/mL in Ham's F-10 medium by exposure to 10 ixmo\/L cupric acetate at room temperature. 25 Oxidation was terminated by addition of BHT to a final concentration of 20 /wnol/L. Because dialysis had no significant effect on the biological activity of oxLDL (see "Results") and increased the risk of endotoxin contamination, oxLDL preparations were not dialyzed. Precautions taken to prevent endotoxin contamination during lipoprotein isolation and oxidation included the use of pyrogen-free sterile water for all reagents. All glassware was washed with 1% E-Toxa-Clean in sterile water, rinsed with sterile water, and baked at 185°C for 5 hours. Endotoxin contamination of reagents and lipoproteins was monitored with the chromogenic LAL assay using E. coli 0111: B4 endotoxin supplied with the kit for the standard curve.
LPS Association With Lipoprotein
Biosynthetically tritiated Re595-LPS 26 
Thiobarbituric Acid-Reactive Substance (TBARS) Assay
TBARS content of the lipoproteins was used as a measure of lipid peroxidation and was assayed by a modification of the method of Steinbrecher et al. 27 Briefly, 0.2 mL of sample containing 40 jug LDL protein and BHT (20 /xmol/L) was assayed by the addition of 1.0 mL 20% trichloroacetic acid followed by 1.0 mL 2-thiobarbituric acid (0.67% in 0.05N NaOH). Samples were heated for 30 minutes at 90°C, cooled, and centrifuged, and the absorbance at 532 nm was compared with that of tetramethoxypropane standards.
Electrophoresis
OxLDL was examined for apoprotein fragmentation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with use of the Phast System (Pharmacia LKB Biotechnology). LDL and oxLDL (0.4 fig protein per lane) were separated on 4% to 15% polyacrylamide gradient gels and stained with silver and Coomassie Blue R, 28 and the gels were photographed.
Cell Culture
Peripheral blood mononuclear cells were isolated from blood samples of normal donors by the Ficoll-Hypaque method as described. 24 Monocytes were isolated from peripheral blood mononuclear cells on Sepracell-MN (Sepratech Corp). The purity of the monocyte preparation was >90% as determined by nonspecific esterase staining. The monocytes were cultured at a density of lxlO 6 cells in 1 mL per well in 24-well tissue-culture dishes in RPMI-1640 (low endotoxin) containing 5% endotoxin-free fetal calf serum, 20 mmol/L HEPES, and 10 /ig/mL gentamicin. Monocytes were allowed to adhere for 1 hour before they were exposed to lipoproteins and/or LPS. Cellular DNA was determined according to Labarca and Pargen. 29 Cellular protein was quantified with a modified Lowry procedure.
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TF Activity
TF activity was determined as described earlier. 13 Cell pellets were solubilized with 15 mmol/L octyl-/3-D-glucopyranoside at 37°C for 15 minutes. TF activity was assayed in cell lysates in a one-stage clotting assay. Equal volumes of prewarmed, citrated human plasma and 20 mmol/L CaCl 2 were added to one volume of test sample, and the clotting times were determined manually by observing clot formation. Typically the clotting volume was 0.3 mL. Functional TF was quantitated by using a standard curve established with phospholipid-reconstituted, affinity-purified TF from human brain. 31 Specificity of this assay for TF was documented by incubating samples with 30 Mg/mL of a neutralizing monoclonal antibody to human TF (TF8-5G9).
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Assay for TNF-a
The L929 cytotoxicity assay was performed as described. 33 Briefly, L929 cells (lxlOVO.l mL) were seeded in 96-well flat-bottom plates for 6 hours at 37°C with actinomycin D (1 jj,g/mL, Calbiochem) at 0.05 mL per well and serial dilutions of test culture supernatant. After a 16-hour incubation viable L929 cells were stained for 1 hour with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolin bromide (2.5 mg/mL, Sigma) (0.04 mL per well). Culture supernatants were removed and cells lysed with 0.1 mL isopropanol containing 40 mmol/L HC1. Photometric measurement was performed at 562 nm on a microplate reader (Micro Devices Corp). Standards were recombinant TNF-a (Genzyme) at concentrations ranging from 2 to 1000 ng/mL.
Assay for IL-8
IL-8 was determined as described. 34 To quantify IL-8 in monocyte supernatants, samples and rabbit antiserum to IL-8 were mixed in phosphate-buffered saline in 1% bovine serum albumin to a final volume of 0.4 mL. After incubation for 30 minutes, 125 I-IL-8 (10 000 cpm) was added to each sample and incubated overnight at 4°C. Iron-conjugated goat anti-rabbit immunoglobulin G (Advanced Magnetics Inc) was added to each sample to a final volume of 0.8 mL. After further incubation for 10 minutes, the samples were pelleted by using a magnetic separation unit (Advanced Magnetics Inc). The titration curve for IL-8 was 0.14 to 100 /ig/mL, and all samples were assayed in duplicate.
Results
Endotoxin Contamination in Lipoprotein Preparations
When adherent monocytes were incubated for 12 hours with increasing concentrations of our initial preparations of oxLDL (the Table, preparation No. 1), we observed a dose-dependent induction of TF activity that exhibited a maximal induction of 87-fold at 80 /iig/mL (Fig 1) . Studies in our laboratory indicate that TF expression is induced in human monocytes exposed to LPS concentrations as low as 10 to 100 pg/mL, although higher concentrations (100 ng/mL) are required to induce maximal TF expression (Steinmann et al, unpublished observations). Therefore, it was possible that contaminating endotoxin present in the oxLDL was partly responsible for the observed induction of TF activity. Lipoprotein preparation No. 1 (the Table) contained such significant levels of endotoxin contami-
Characterization of Lipoprotein Preparations
Preparation No. TF indicates tissue factor; TBARS, thiobarbituric acid-reactive substance; LDL, low-density lipoprotein; oxLDL, oxidized LDL; and NA, not assayed.
*TF activity was measured after 12 hours in response to 80 jug/mL oxLDL.
nation that maximal doses of lipoprotein produced an endotoxin concentration of 85 pg/mL and 1.22 ng/mL for LDL and oxLDL, respectively. Nevertheless, this contaminating endotoxin alone did not appear to account for the observed 87-fold induction of TF activity, because exogenously added LPS (10 ng/mL) led to only a 21-fold induction (Fig 2) . One possible explanation was that endotoxin and oxLDL acted in concert to induce TF activity in monocytes. Therefore, we made great efforts to prepare LDL and oxLDL with virtually no endotoxin contamination (<1 pg//xg lipoprotein, the Table) . No induction of TF activity was observed in adherent monocytes incubated for 12 hours with 80 /xg/mL of endotoxin-free oxLDL or native LDL (Fig 1) . These data indicated that oxLDL, in the absence of significant levels of contaminating endotoxin, did not induce TF activity in adherent monocytes.
OxLDL Enhances LPS-Induced TF Activity
To verify that addition of oxLDL could enhance the induction of TF activity in monocytes exposed to LPS, we incubated monocytes for 12 hours with increasing concentrations of LPS (0.01 to 10 ng/mL) in the absence or presence of 80 ^tg/rnL endotoxin-free LDL or oxLDL (Fig 2) . The concentrations of LPS in these experiments were calculated to be similar to those of contaminating endotoxin observed in lipoprotein preparation No. 1 (the Table) . Unstimulated monocytes expressed very low levels of TF activity. As expected, LPS alone induced TF activity in a dose-dependent manner, with a minimal effective concentration of 1 ng/mL. However, induction of TF activity in cells incubated with both LPS (1 to 10 ng/mL) and oxLDL (80 /xg/mL) was significantly higher than that observed with LPS alone. Ox-LDL caused a 3.5±1.0-fold (n=3) enhancement of the effect of 10 ng/mL LPS. In contrast, the presence of native LDL (80 /ig/mL) derived from the identical lipoprotein preparation had no effect on induction of TF activity by exogenously added LPS (Fig 2) . After dialysis against Ham's F-10 medium, oxLDL lost 65% of its TBARS but effected a 2.8-fold enhancement of TF activity induced by 10 ng/mL LPS (data not shown). Cupric acetate alone had no effect on LPS induction of TF activity (data not shown).
Because LPS is known to associate with lipoproteins, 35 enhancement of LPS-induced TF activity by oxLDL might be explained by a preferential association of LPS with oxLDL. Therefore, we coincubated [ 
Time Course of TF Induction
The kinetics of TF induction in monocytes by 10 ng/mL LPS alone and in the presence of oxLDL or native LDL (80 /Ag/mL) was examined. Adherent LPSstimulated monocytes exhibited a 15-fold increase in functional TF activity, which was maximal at 12 hours (Fig 3) . This LPS induction of TF was enhanced 3.4-fold by oxLDL, with a similar maximal effect at 12 hours (Fig  3) . TF activity in cells coincubated with LPS and oxLDL decreased at 18 hours but remained elevated in comparison with the TF activity observed in cells treated with LPS alone. In contrast, native LDL (80 (ig/mL) had no effect on the LPS-stimulated increase in TF activity. Monocytes incubated in medium alone exhibited no increase in TF expression. When monocytes were exposed to oxLDL (80 /ig/mL) for 12 hours before the 12-hour incubation with LPS (10 ng/mL), TF activity was again enhanced 2.6-fold (data not shown).
Dose Response of TF Induction by OxLDL in the Presence of LPS
We examined the dose response of oxLDL for enhancement of LPS-induced TF activity. As shown in Fig  4, monocytes were incubated for 12 hours with 10 ng/mL LPS and increasing concentrations of oxLDL or native LDL (10 to 80 Aig/mL). LPS-induced TF activity was significantly enhanced in a dose-dependent manner by oxLDL, with a maximal effect at the highest dose Table, preparation No. 4) for up to 24 hours. Cells were harvested every 6 hours and tissue factor activity was determined as described in "Methods." This experiment is representative of three independent experiments with three different lipoprotein preparations.
tested (80 jig/mL). Incubation with LPS and native LDL resulted in a slight increase in the level of LPSinduced TF activity at the highest dose tested compared with LPS alone (Fig 4) . In additional experiments, higher concentrations of oxLDL were consistently less effective and appeared to be toxic to the cells (data not shown).
Effect of LDL Oxidized for Different Time Intervals
LDL was oxidized for different time intervals (0,1, 2, 4, 9, 24, and 48 hours) and tested for its effect on Table, preparation No. 7) that had been oxidized for different time intervals (0, 1, 2, 4, 9, 24, and 48 hours). Lipoprotein preparations were characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (upper panel) and thiobarbituric acid-reactive substance (TBARS) assay (middle panel), as described in "Methods." Tissue factor activity was determined as described in "Methods" (lower panel). The experiment is representative of two independent studies with two different lipoprotein preparations.
LPS-induced TF activity (Fig 5) . Oxidation of the lipoproteins was characterized by SDS-PAGE and the TBARS assay that revealed a time-dependent loss or fragmentation of apolipoprotein (apo) B-100, as evidenced by Coomassie Blue R staining (Fig 5, upper  panel) , and a time-dependent increase in TBARS, a measure of lipid peroxidation (Fig 5, center panel) . In addition, conjugated-diene generation in oxLDL (increases of 0.137, 0.375, and 0.595 absorbance units at 1, 2, and 4 hours, respectively, as monitored by UV absorbance at 234 nm) indicated a faster rate of LDL modification than was evidenced by apo B fragmentation or TBARS formation. LPS (10 ng/mL) alone induced TF activity 15-fold, which was not changed by the presence of sham-oxidized LDL (control LDL containing copper and BHT; "0 h" oxidation in Fig 5, lower  panel) . In contrast, LDL oxidized for as little as 1 hour enhanced LPS-induced TF activity 3.1-fold, and maximal enhancement was observed for LDL samples oxidized for 9 hours (4.8-fold). Oxidation for 24 or 48 hours did not further increase the effect of oxLDL on LPS-induced TF activity, although it did increase apo B-100 protein fragmentation and TBARS content of the lipoprotein. It is interesting that a 1-hour exposure to Cu 2+ was sufficient to initiate significant oxidation as measured by the TF response, suggesting that induction of TF expression, apo B fragmentation, and conjugateddiene formation are more sensitive measures of oxLDL activity than the TBARS assay. It is important to note that the degree of oxidation measured by SDS-PAGE, TBARS, and conjugated-diene formation represented LDL modifications that existed before it was added to the adherent monocyte cultures. Further cell-mediated modification of LDL may have occurred during the 12-hour culture period despite the presence of serum and BHT in the cultures. This experiment also served as a control for endotoxin contamination, because all samples were derived from a single LDL sample and yet, after oxidation, the samples had different abilities to enhance LPS-induced TF activity.
Effect of OxLDL on LPS-induced Production of TNF-a and IL-8
To document the specificity of the enhancing effect of oxLDL on TF induction by LPS, we examined the effect of this modified lipoprotein on monocyte expression of two other LPS-inducible pro-inflammatory cytokines, TNF and IL-8.
3637 TNF has been implicated as playing a role in atherosclerotic plaque development. 38 Furthermore, oxLDL inhibits LPS-induced expression of TNF mRNA in murine macrophages. 10 In a separate study, we have documented induction of IL-8 in human monocytes and monocytic THP-1 cells by endotoxin-free oxLDL. 39 IL-8 has the potential to affect atherogenesis by virtue of its ability to chemoattract T lymphocytes 37 and to induce angiogenesis. 40 Both cytokines were measured in the 12-hour supernatants obtained from the LPS dose-response experiment shown in Fig 2. In agreement with the previous report, 10 oxLDL dramatically inhibited LPSinduced production of TNF (Fig 6) . In contrast, oxLDL did not modulate LPS-stimulated IL-8 production, although in agreement with our previous data, 39 oxLDL alone induced IL-8 expression (Fig 7) .
Discussion
It has been suggested that oxLDL modulates functions of monocytic cells within atherosclerotic lesions.' This study demonstrated that in addition to reported direct effects, oxLDL also modulated LPS-induced gene expression in human adherent monocytes. Whereas oxLDL alone, which was free of significant detectable levels of LPS contamination, did not induce TF activity, this oxLDL consistently enhanced LPS-induced TF activity in human adherent monocytes in a time-and dose-dependent manner. Native LDL had no effect on TF expression. In contrast, oxLDL dramatically inhibited LPS-induced secretion of TNF, as described in an earlier report on murine macrophages, 10 and did not change LPS-mediated production of IL-8. Moreover, oxLDL inhibited LPS-induced IL-la, IL-1/3, and IL-6 production in murine macrophages. 9 Many of these inflammatory products expressed by monocytic cells may play important roles in plaque development. 1314 ' 3738 ' 40 The data presented in this study indicate that oxLDL differentially affects the pattern of LPS-induced monocytic gene expression. This is the first 0.1 1 LPS (ng/ml) report to our knowledge of an enhancement of LPSinducible gene expression by oxLDL.
Three lines of evidence support our conclusion that enhancement of LPS-induced TF activity by oxLDL is not due to additional contaminating LPS but rather to direct or indirect cooperation between oxLDL and LPS. First, the levels of contaminating LPS in the oxLDL preparations were in all cases below those required to increase TF activity in monocytes under our culture conditions. Second, the endotoxin levels in control LDL were comparable with those in oxLDL, but control lipoproteins had no enhancing effect on LPS-induced TF expression. Third, in studies designed to determine the effect of the duration of oxidation of LDL, all samples were removed from a single oxidation mixture (and therefore had identical LPS levels), yet induction of TF activity was dependent on the time of oxidation.
Modulation of the effects of LPS by oxLDL may result from a direct extracellular interaction between LPS and oxLDL. 35 However, we were unable to document a preferential association between [
3 H]Re595-LPS and oxLDL. It is equally possible that cooperative interactions between oxLDL and LPS occur intracellularly. Both oxidative stress and LPS activate the N F -K B / Rel family of transcription factors. 4142 These proteins play an essential role in the transcriptional regulation of several LPS-inducible genes expressed in monocytic cells. 42 Recently we have demonstrated that a «:B-like DNA element in the human TF promoter mediates LPS induction of TF expression in THP-1 monocytic cells. 14 Furthermore, minimally modified LDL injected into atherosclerosis-susceptible mice increases liver expression of a set of inflammatory gene products involved in atherosclerosis 43 that may be regulated by NF-KB. 4 4 OxLDL may exert oxidative stress on the cells and thereby contribute to intracellular signals that increase the magnitude of activation of some or all of the NF-KB/Rel family of transcription factors. Further studies are necessary to characterize the cellular, biochemical, and molecular mechanisms responsible for oxLDL amplification of the TF response to LPS. No direct effect of oxLDL on TF activity was observed in adherent monocytes when LPS contamination of our lipoprotein preparations was reduced to <0.8 pg//u,g lipoprotein. Our results differ from an earlier report that demonstrated induction of TF expression in monocytes/macrophages by chemically modified LDL at doses of 25 to 750 /xg/mL. 15 In addition, our preliminary studies with the human monocytic cell line THP-1 indicated that oxLDL directly induces TF mRNA and TF activity. 16 Minimally modified LDL and oxLDL also directly induce TF expression in endothelial cells.
1718
These discrepancies may be due to differences in the differentiation state of the monocytic cells, differences in TF regulation in monocytes versus endothelial cells, or the type and degree of modification of LDL. However, the rigorous precautions we found necessary to reduce endotoxin contamination of lipoproteins during isolation and particularly during oxidation suggest that endotoxin contamination may account for some of the conflicting results. Thus, our study should serve as a caveat for all experiments designed to examine the effect of lipophilic molecules, such as lipoproteins, on the expression of LPS-sensitive genes in monocytic cells. It emphasizes the importance of accurate and sensitive screening for endotoxin at all stages of lipoprotein isolation and modification.
In summary, our study demonstrated that oxLDL significantly enhanced LPS-induced TF activity in adherent monocytes. LPS is responsible for many of the cellular responses to Gram-negative bacterial infections, 45 including induction of TF. 1314 - 20 Therefore, these studies indicate that an in vitro relationship exists between LPS and oxLDL and may parallel a pathogenic relationship in vivo. Monocytes are exposed to endotoxins in plasma and to oxLDL after recruitment into the artery wall. In addition, endotoxins may leak through the defective endothelial barrier in atherosclerotic lesions. Finally, endotoxins may be carried within the LDL or oxLDL particle, so cells would be exposed to the two pathogenic factors simultaneously. Thus, monocytes exposed to endotoxins and oxLDL in the intimal lesion may express increased levels of TF that can contribute to a hypercoagulatory state and to thrombotic events associated with atherosclerosis.
